David Baldwin

2.4k total citations
48 papers, 1.8k citations indexed

About

David Baldwin is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, David Baldwin has authored 48 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in David Baldwin's work include Diabetes Management and Research (16 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (16 papers) and Diabetes and associated disorders (11 papers). David Baldwin is often cited by papers focused on Diabetes Management and Research (16 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (16 papers) and Diabetes and associated disorders (11 papers). David Baldwin collaborates with scholars based in United States, Australia and Thailand. David Baldwin's co-authors include Arthur H. Rubenstein, Jerrold M. Olefsky, Steven R. Daugherty, Robert Mcnutt, D F Steiner, Susan Terris, Christina Munoz, Beverley Davies Rowley, José Goldman and Bruce D. Given and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

David Baldwin

48 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Baldwin United States 25 1.0k 493 468 463 128 48 1.8k
Asma Deeb United Arab Emirates 22 731 0.7× 509 1.0× 468 1.0× 378 0.8× 8 0.1× 98 1.4k
Silvia Ippolito Italy 22 440 0.4× 274 0.6× 90 0.2× 161 0.3× 19 0.1× 57 1.3k
Klaus Kapelari Austria 17 341 0.3× 281 0.6× 162 0.3× 83 0.2× 21 0.2× 41 1.0k
Samuel J. Casella United States 22 877 0.9× 688 1.4× 349 0.7× 292 0.6× 3 0.0× 37 1.7k
Valdemar Ortiz Brazil 24 208 0.2× 361 0.7× 90 0.2× 707 1.5× 10 0.1× 160 1.9k
Steven Masson United Kingdom 23 353 0.4× 492 1.0× 77 0.2× 292 0.6× 18 0.1× 84 2.0k
David S. López United States 20 524 0.5× 652 1.3× 152 0.3× 251 0.5× 4 0.0× 80 2.1k
Gun Forsander Sweden 29 1.7k 1.7× 153 0.3× 1.6k 3.4× 1.2k 2.6× 5 0.0× 91 2.4k
Peter J. Stahl United States 23 160 0.2× 402 0.8× 217 0.5× 286 0.6× 7 0.1× 60 1.4k
Denis Morin France 18 54 0.1× 452 0.9× 166 0.4× 181 0.4× 91 0.7× 51 1.4k

Countries citing papers authored by David Baldwin

Since Specialization
Citations

This map shows the geographic impact of David Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Baldwin more than expected).

Fields of papers citing papers by David Baldwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Baldwin. The network helps show where David Baldwin may publish in the future.

Co-authorship network of co-authors of David Baldwin

This figure shows the co-authorship network connecting the top 25 collaborators of David Baldwin. A scholar is included among the top collaborators of David Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Baldwin. David Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vellanki, Priyathama, Neda Rasouli, David Baldwin, et al.. (2018). Glycaemic efficacy and safety of linagliptin compared to a basal‐bolus insulin regimen in patients with type 2 diabetes undergoing non‐cardiac surgery: A multicentre randomized clinical trial. Diabetes Obesity and Metabolism. 21(4). 837–843. 50 indexed citations
2.
Reutrakul, Sirimon, et al.. (2014). Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease. Clinical Kidney Journal. 7(3). 248–250. 48 indexed citations
3.
Kim, Yoojin, Weihua Gao, Mary Ann Emanuele, et al.. (2014). The Association Between Glycemic Control and Clinical Outcomes after Kidney Transplantation. Endocrine Practice. 20(9). 894–900. 13 indexed citations
4.
Baldwin, David, et al.. (2012). Management of Hyperglycemia in Hospitalized Patients with Renal Insufficiency or Steroid-Induced Diabetes. Current Diabetes Reports. 13(1). 114–120. 30 indexed citations
5.
Munoz, Christina, et al.. (2011). Treatment of inpatient hyperglycemia beginning in the emergency department: A randomized trial using insulins aspart and detemir compared with usual care. Journal of Hospital Medicine. 6(5). 279–284. 20 indexed citations
6.
Munoz, Christina, et al.. (2008). Impact of a Subcutaneous Insulin Protocol in the Emergency Department: Rush Emergency Department Hyperglycemia Intervention (REDHI). Journal of Emergency Medicine. 40(5). 493–498. 19 indexed citations
7.
8.
Baldwin, David, et al.. (2006). Comparison of Once-Daily Glargine Insulin with Twice-Daily NPH/Regular Insulin for Control of Hyperglycemia in Inpatients After Cardiovascular Surgery. Diabetes Technology & Therapeutics. 8(6). 609–616. 21 indexed citations
9.
Baldwin, David, et al.. (2006). Urinary Albumin Excretion in Patients With Diabetes After Renal Transplantation. Transplantation Proceedings. 38(9). 2879–2882. 1 indexed citations
10.
Chen, Wan, et al.. (2005). Culturally competent diabetic education to lower hemoglobin A1c levels of diabetic patients: Está mejor.. PubMed. 101(6). 54–6. 3 indexed citations
11.
Maxhimer, Justin B., Geetha Rao, Catherine Pesce, et al.. (2005). Heparanase-1 Gene Expression and Regulation by High Glucose in Renal Epithelial Cells. Diabetes. 54(7). 2172–2178. 98 indexed citations
12.
Baldwin, David, et al.. (2004). ROSIGLITAZONE TREATMENT OF DIABETES MELLITUS AFTER SOLID ORGAN TRANSPLANTATION. Transplantation. 77(7). 1009–1014. 41 indexed citations
13.
Baldwin, David, et al.. (2004). Pioglitazone in the Management of Diabetes Mellitus after Transplantation. American Journal of Transplantation. 4(12). 2135–2138. 68 indexed citations
14.
Baldwin, David, Steven R. Daugherty, & Beverley Davies Rowley. (1996). Residentsʼ and medical studentsʼ reports of sexual harassment and discrimination. Academic Medicine. 71(10). S25–7. 29 indexed citations
15.
Baldwin, David, Steven R. Daugherty, & Beverley Davies Rowley. (1994). Racial and ethnic discrimination during residency. Academic Medicine. 69(10). S19–21. 28 indexed citations
16.
Baldwin, David, et al.. (1993). Students from Disadvantaged Backgrounds: Satisfaction with a Mentor-Protégé Relationship. Journal of Nursing Education. 32(5). 225–226. 8 indexed citations
17.
Rowley, Beverley Davies & David Baldwin. (1988). Substance abuse policies and programs at U.S. medical schools. Academic Medicine. 63(10). 759–61. 6 indexed citations
18.
Baldwin, David, et al.. (1988). Casualties of residency training: a national study of loss and attrition.. PubMed. 27. 112–7. 8 indexed citations
19.
Rosenfeld, Ron G., David Baldwin, Laura A. Dollar, et al.. (1981). Simultaneous Inhibition of Insulin and Somatomedin-C Binding to Cultured IM-9 Lymphocytes by Naturally Occurring Antireceptor Antibodies. Diabetes. 30(11). 979–982. 18 indexed citations
20.
Baldwin, David, et al.. (1979). Insulin-Resistant Diabetes with Insulin Receptor Autoantibodies in a Male Patient Without Acanghosis Nigricans. Diabetes Care. 2(3). 275–277. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asma Deeb Breakdown of academic impact, for papers by Silvia Ippolito Breakdown of academic impact, for papers by Klaus Kapelari Breakdown of academic impact, for papers by Samuel J. Casella Breakdown of academic impact, for papers by Valdemar Ortiz Breakdown of academic impact, for papers by Steven Masson Breakdown of academic impact, for papers by David S. López Breakdown of academic impact, for papers by Gun Forsander Breakdown of academic impact, for papers by Peter J. Stahl Breakdown of academic impact, for papers by Denis Morin
Rankless by CCL
2026